SCHEMBL29475724

SCHEMBL29475724

CCCCOc1cc2c([nH]c(=O)n2Cc2ccc(CN3CCC(C4CCN(C(=O)[C@@H](N)CCCCNC(=O)CON)CC4)CC3)cc2)c(N)n1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 20/20 0.39
▸ IL6 P05231 9/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29034537 1.00 TLR7 (0.39) TLR7IL6
SCHEMBL22359154 0.93 TLR7 (0.39) TLR7IL6
SCHEMBL22359142 0.89 TLR7 (0.40) TLR7IL6
SCHEMBL28659945 0.89 TLR7 (0.40) TLR7IL6
SCHEMBL26347255 0.88 TLR7 (0.53) TLR7IL6
SCHEMBL29034532 0.81 CHRM4 (0.44) TLR7IL6
SCHEMBL26348223 0.81 TLR7 (0.42) TLR7IL6
SCHEMBL26348222 0.80 TLR7 (0.45) TLR7IL6
SCHEMBL29475681 0.79 BCHE (0.42) TLR7IL6
SCHEMBL26348220 0.78 TLR7 (0.52) TLR7IL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119455003-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 — — CN disclosed
CN-119455004-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 — — CN disclosed
CN-116457023-A antibody-TLR agonist conjugates, methods and uses thereof AMBRX公司 2023-07-18 — — CN disclosed
EP-4199968-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF Ambrx, Inc. (US) 2023-06-28 — — EP disclosed
WO-2022040596-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF AMBRX, INC. (US) 2022-02-24 — — WO disclosed
Send feedback